First authors, institutions, and titles of the 9 abstracts presented at the GRAPPA Fellows Symposium 2013.
| First Author | Institution | Abstract Title |
|---|---|---|
| A. Shrestha | Department of Rheumatology, Albert Einstein College of Medicine, New York, NY, USA | Higher disease activity in psoriatic arthritis (PsA) is associated with elevated total cholesterol and triglycerides |
| M. Morgan | Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, Utah, USA | Fatigue and work disability in PsA |
| R. Aslanov | Nexux Clinical Research, Memorial University of Newfoundland, St. John’s, NL, Canada | PsA and malignancy: a prospective cohort study |
| L. Eder | Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto, ON, Canada | Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with PsA |
| L. Burns | Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada | The independent impact of depression on incident myocardial infarction in psoriatic disease: a population-based cohort study |
| L. Kilic | Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey | Patient-derived PsA Impact of Disease correlates with other outcome measures |
| V. Scaglioni | Division of Rheumatology, Hospital Italiano de Buenos Aires, Argentina | Remission criteria and activity indices in PsA and their relationship with skin involvement |
| S. Au | Tufts Medical Center, Boston, MA, USA | A comparison of psoriasis drug failure rates in biologics vs conventional systemic therapies |
| A. N. Boca | Department of Dermatology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania | Genetic variants of IL-6 and IL-12B — decreased risk of psoriasis |
IL: interleukin.